DE10390251D2 - Trojanische Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung - Google Patents

Trojanische Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung

Info

Publication number
DE10390251D2
DE10390251D2 DE10390251T DE10390251T DE10390251D2 DE 10390251 D2 DE10390251 D2 DE 10390251D2 DE 10390251 T DE10390251 T DE 10390251T DE 10390251 T DE10390251 T DE 10390251T DE 10390251 D2 DE10390251 D2 DE 10390251D2
Authority
DE
Germany
Prior art keywords
trojan
inhibitors
processes
production
trojan inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE10390251T
Other languages
English (en)
Inventor
Ulrich Schubert
Evelyn Schubert
Uwe Tessmer
Kerstin Lucas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VIROMICS GmbH
Original Assignee
VIROMICS GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VIROMICS GmbH filed Critical VIROMICS GmbH
Priority to DE10390251T priority Critical patent/DE10390251D2/de
Application granted granted Critical
Publication of DE10390251D2 publication Critical patent/DE10390251D2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE10390251T 2002-01-27 2003-01-27 Trojanische Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung Expired - Fee Related DE10390251D2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE10390251T DE10390251D2 (de) 2002-01-27 2003-01-27 Trojanische Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10203862 2002-01-27
DE10204210 2002-01-27
DE10209064 2002-02-28
PCT/DE2003/000265 WO2003064453A2 (de) 2002-01-27 2003-01-27 Trojanische inhibitoren, verfahren zu ihrer herstellung und ihre verwendung
DE10390251T DE10390251D2 (de) 2002-01-27 2003-01-27 Trojanische Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
DE10390251D2 true DE10390251D2 (de) 2004-12-23

Family

ID=27669716

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10304202A Withdrawn DE10304202A1 (de) 2002-01-27 2003-01-27 Trojanische Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung
DE10390251T Expired - Fee Related DE10390251D2 (de) 2002-01-27 2003-01-27 Trojanische Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10304202A Withdrawn DE10304202A1 (de) 2002-01-27 2003-01-27 Trojanische Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung

Country Status (3)

Country Link
AU (1) AU2003208275A1 (de)
DE (2) DE10304202A1 (de)
WO (1) WO2003064453A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0201863D0 (en) * 2002-06-18 2002-06-18 Cepep Ab Cell penetrating peptides
DE102006008321A1 (de) * 2006-02-17 2007-08-30 Virologik Gmbh Mittel zur Behandlung von Infektionen mit Influenzaviren
WO2012038950A1 (en) 2010-09-20 2012-03-29 Ramot At Tel-Aviv University Ltd. Activatable toxin complexes comprising a cleavable inhibitory peptide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1818299A (en) * 1997-12-10 1999-06-28 Washington University Anti-pathogen system and methods of use thereof
WO2002072790A2 (en) * 2001-03-14 2002-09-19 Myriad Genetics, Inc Tsg101-gag interaction and use thereof
WO2003015708A2 (en) * 2001-08-18 2003-02-27 Myriad Genetics, Inc Composition and method for treating hiv infection

Also Published As

Publication number Publication date
WO2003064453A3 (de) 2004-02-12
AU2003208275A1 (en) 2003-09-02
DE10304202A1 (de) 2003-12-04
WO2003064453A2 (de) 2003-08-07

Similar Documents

Publication Publication Date Title
DE10393704D2 (de) Nancomposite, Verfahren zu ihrer Herstellung und ihre Verwendung
ATE347890T1 (de) Diarylcycloalkylderivate, verfahren zu ihrer herstellung und ihre verwendung als ppar- aktivatoren
ATE348609T1 (de) Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
DE60313602D1 (de) N-iPHENYL(PIPERIDIN-2-YL)METHYLöBENZAMIDDERIVATE,VERFAHREN ZU IHRER HERSTELLUNG UND IHRE THERAPEUTISCHE ANWENDUNG
ATA10182002A (de) Diamantelektrode und verfahren zu ihrer herstellung
ATE476412T1 (de) Acyl-4-carboxy-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung
DE60334183D1 (de) Faserplatte und Verfahren zu ihrer Herstellung
DE502005007840D1 (de) 7-phenylamino-4-chinolon-3-carbonsäure-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE502004011957D1 (de) Neue cyanopyrrolidide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE50312261D1 (de) Heterozyklisch substituierte benzoylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE554113T1 (de) Butencopolymere und verfahren zu ihrer herstellung
ATE327981T1 (de) Arylisoxazolin-derivative, verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel
DE50310782D1 (de) Piezoaktor und verfahren zu dessen herstellung
ATE271037T1 (de) Substituierte karbazole, verfahren zu ihrer herstellung und ihre verwendung als spla2- inhibitoren
ATE473738T1 (de) 1-sulfonylindolderivate, verfahren zu ihrer herstellung und ihre verwendung als 5-ht6 liganden
ATE272634T1 (de) Benzothiophenderivate, verhahren zu ihrer herstellung und ihre verwendung
ATE384069T1 (de) Alkyliden-tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
DE50307428D1 (de) Sitzeinlage und verfahren zu ihrer herstellung
DE502004005578D1 (de) Hochtackige klebmasse, verfahren zu deren herstellung und deren verwendung
ATE517853T1 (de) Mörtelzusammensetzung, verfahren zu ihrer herstellung und ihre verwendung
DE50306943D1 (de) Pflanzliche plazenta-extrakte, verfahren zu ihrer herstellung und ihre verwendung
DE03743522T1 (de) Wässrige dispersion, verfahren zu ihrer herstellung und ihre verwendung
ATE404532T1 (de) Acyl-3-carboxyphenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung
DE60205717D1 (de) 2-arylimino-2,3-dihydrothiazol derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
PT1663997E (pt) 1h-azolilmetilamidas, processos para a sua produção e a sua utilização como inibidores de nitrificação

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee